Related Experiment Videos
[The risk and treatment of hyperlipoproteinemias]
P Alzamora1, E Alegría, I Iglesias
1Departamento de Cardiología y Cirugía Cardiovascular, Facultad de Medicina, Universidad de Navarra, Pamplona.
Revista De Medicina De La Universidad De Navarra
|January 1, 1990
Insights
Lipid disorders significantly contribute to coronary heart disease development. This review covers hyperlipidemia pathophysiology and current treatment strategies for managing these lipid disorders.
Area of Science:
- Cardiology
- Metabolic Disorders
- Biochemistry
Context:
- Coronary heart disease (CHD) remains a leading cause of mortality worldwide.
- Lipid metabolism plays a critical role in cardiovascular health.
- Understanding hyperlipidemias is essential for effective CHD prevention and management.
Purpose:
- To review the intricate role of lipid disorders in the pathogenesis of coronary heart disease.
- To elucidate the pathophysiology of various hyperlipidemias.
- To outline current therapeutic policies for managing lipid disorders.
Summary:
- This review synthesizes current knowledge on how lipid disorders contribute to the development of coronary heart disease.
- It details the underlying pathophysiology of hyperlipidemias, including genetic and lifestyle factors.
- Current pharmacological and non-pharmacological treatment strategies are discussed.
Impact:
- Provides a comprehensive overview for clinicians and researchers on lipid disorders and CHD.
- Highlights the importance of targeted lipid management in cardiovascular disease prevention.
- Informs future research directions in lipid metabolism and cardiovascular therapeutics.
Abstract:
The role of lipid disorders in the pathogenesis of coronary heart disease is reviewed. It is also presented the pathophysiology of hyperlipidemias and its current therapeutic policies.